Document is current
Any future updates will be listed below
-
Authors
Lie, Yenni https://orcid.org/0000-0002-6758-6435
Mathers, Susan
Hosken, Ruth
Stout, Julie C.
Mercieca, Emily
Xu, Yufei
Ma, Henry
Phan, Thanh G.
- License Information
-
More Information
Article History
Received: 6 March 2026
Accepted: 21 July 2026
First Online: 28 July 2026
Declarations
Ethics approval and consent to participate: The study was approved by the Research Ethics and Ethics Committee at Calvary Health Care Bethlehem (CHCB 21,081,905) and conducted in accordance with the Declaration of Helsinki. The Committee waived the requirement for individual patient consent due to the retrospective use of de-identified data.
Consent for publication: Not applicable.
Competing interests: TGP has received honoraria as a speaker from Genzyme, Boehringer Ingelheim, Pfizer, Bristol Myers Squibb (BMS), and Bayer, and is on the advisory board for Genzyme on Fabry disease. All other authors declare no competing interests.
